Interestingly, some research indicates that PPIs might be repurposed as adjunctive agents in cancer treatment. For example, PPIs may enhance the effectiveness of chemotherapy by altering the pH of the tumor microenvironment, making cancer cells more susceptible to treatment. However, this is still an emerging area of research and clinical trials are necessary to validate these findings.